PUTNAM INVESTMENTS LLC - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 67 filers reported holding IMMUNE DESIGN CORP in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2016$1,201,000
-37.5%
218,362
-13.8%
0.00%
-40.0%
Q3 2016$1,921,000
-16.7%
253,386
-10.4%
0.01%
-16.7%
Q2 2016$2,307,000
-37.4%
282,683
-0.3%
0.01%
-33.3%
Q1 2016$3,687,000
-34.9%
283,656
+0.6%
0.01%
-30.8%
Q4 2015$5,662,000
+64.0%
281,982
-0.4%
0.01%
+62.5%
Q3 2015$3,453,000
-40.6%
282,990
+0.5%
0.01%
-33.3%
Q2 2015$5,814,000281,5310.01%
Other shareholders
IMMUNE DESIGN CORP shareholders Q4 2015
NameSharesValueWeighting ↓
ProQuest Associates IV LLC 1,236,394$4,080,0004.69%
Versant Venture Management, LLC 2,208,210$7,287,093,0002.33%
EcoR1 Capital, LLC 4,437,600$14,422,0001.45%
BVF INC/IL 4,106,200$13,550,0001.37%
Abingworth LLP 352,300$1,145,0000.71%
DAFNA Capital Management LLC 328,500$1,084,0000.53%
Bain Capital Public Equity Management, LLC 1,680,987$5,547,0000.40%
Telemetry Investments, L.L.C. 248,800$821,0000.31%
Stonepine Capital Management, LLC 161,226$532,0000.28%
Focused Wealth Management, Inc 12,395$41,0000.01%
View complete list of IMMUNE DESIGN CORP shareholders